In head and neck malignant tumors, overexpression of HDAC9 promotes carcinogenesis by targeting the transcription factor MEF2D and the proapoptotic MEF2 target, NR4A1/Nur77 [40, 41]. Here, MEF2D is linked to head and neck cancer.